Press release from the Competition Council regarding the economic concentration project concerning the joint takeover by ‘Eurazeo SE’, through the investment fund ‘Nov Santé Actions Non Cotées Assureurs – Caisse des Dépôts Relance Durable France’, and the investment company ‘Crédit Mutuel Equity SCR’ of the company ‘Holding Proteor SAS’

In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 adopted for its implementation, as amended and supplemented, the Competition Council makes available to the public the ‘summary of the operation’ below, containing the information provided by the parties.

This information was prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation.

The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 adopted for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented.

Names of the companies and groups concerned:

• Acquirer 1: ‘Eurazeo SE’, through the fund ‘Nov Santé Actions Non Cotées Assureurs – Caisse des Dépôts Relance Durable France’;
• Acquirer 2: ‘Crédit Mutuel Equity SCR’;
• The target: ‘Holding Proteor SAS’.

Nature of the operation:

• Joint takeover.

Economic sectors concerned:

• Market for the manufacture of prostheses, orthoses, and corsets.

Deadline for interested third parties to submit their observations:

• 10 days from the date of publication of this press release, i.e., September 15, 2025.

NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES

The Competition Council received notification of an economic concentration operation concerning the joint takeover by the company ‘Eurazeo SE’, through the fund ‘Nov Santé Actions Non Cotées Assureurs – Caisse des Dépôts Relance Durable France’, and ‘Crédit Mutuel Equity SCR’ of the company ‘Holding Proteor SAS’ through the acquisition of 10.64% each of the capital and associated voting rights.

‘Eurazeo’ is a European company registered with the Commercial Court of Paris under number 692 030 992, with its registered office at 66 rue Pierre Charron, 75008 Paris, France. ‘Eurazeo’ is an investment company that aims to identify, accelerate, and enhance the transformation potential of companies of all sizes in which it invests. Its three main activities are private equity, private debt, and real estate and infrastructure asset management.

‘Crédit Mutuel Equity SCR’ is a simplified joint-stock company registered with the Paris Trade and Companies Register under number 317 586 220, with its registered office at 25-27 rue des Pyramides 75001 Paris, France. ‘Crédit Mutuel Equity’ encompasses all the investment activities of ‘Crédit Mutuel Alliance Fédérale’ and provides capital support to executives at all stages of their companies’ development, from seed funding to transfer.

‘Holding Proteor’ is a simplified joint-stock company, with its registered office at Saint-Apollinaire (21850) 6, rue de la Redoute, registered with the Dijon Trade and Companies Register under number 383 809 753. ‘Holding Proteor’, through its subsidiaries, is active in the manufacture of prostheses and orthoses.

 

Done in Rabat, on September 4, 2025